RecruitingInterventional · Not applicableNCT05102019 ↗Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
RecruitingInterventional · Phase 2NCT07048808 ↗Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (With 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and SafetyJaikirshan KhatriPIInterventionCombination product: XC001 · Combination product: Sham (No Treatment)DatesJul 2025 – Jun 2027 (est.)SponsorXyloCorRefractory AnginaCoronary Artery Disease